{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T20:33:22Z","timestamp":1744144402057,"version":"3.37.3"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T00:00:00Z","timestamp":1705968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T00:00:00Z","timestamp":1705968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s11910-024-01330-5","type":"journal-article","created":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T08:02:37Z","timestamp":1705996957000},"page":"27-33","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Lobar Microbleeds in the Posterior Cortical Atrophy Syndrome: A Comparison to Typical Alzheimer\u2019s Disease"],"prefix":"10.1007","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3147-8595","authenticated-orcid":false,"given":"Victoria S.","family":"Pelak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vishal","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Serva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Pressman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asher","family":"Mahmood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lily","family":"Noteboom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brianne M.","family":"Bettcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan H.","family":"Sillau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew L.","family":"Callen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashesh A.","family":"Thaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,23]]},"reference":[{"key":"1330_CR1","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.jalz.2017.01.014","volume":"13","author":"SJ Crutch","year":"2017","unstructured":"\u2022\u2022 Crutch SJ, Schott JM, Rabinovici GD, et al. Consensus classification of posterior cortical atrophy. Alzheimers Dement. 2017;13:870\u201384. https:\/\/doi.org\/10.1016\/j.jalz.2017.01.014. This manuscript outlines the consensus criteria for the diagnosis of PCA and provides a framework for the incorporation of biomarkers for the underlying disease.","journal-title":"Alzheimers Dement."},{"key":"1330_CR2","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/S1474-4422(20)30440-3","volume":"20","author":"J Graff-Radford","year":"2021","unstructured":"Graff-Radford J, Yong KXX, Apostolova LG, et al. New insights into atypical Alzheimer\u2019s disease in the era of biomarkers. Lancet Neurol. 2021;20:222\u201334. https:\/\/doi.org\/10.1016\/S1474-4422(20)30440-3.","journal-title":"Lancet Neurol"},{"key":"1330_CR3","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/S1474-4422(22)00208-3","volume":"21","author":"A Charidimou","year":"2022","unstructured":"\u2022\u2022 Charidimou A, Boulouis G, Frosch MP, et al. The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective. MRI-neuropathology diagnostic accuracy study Lancet Neurol. 2022;21:714\u201325. https:\/\/doi.org\/10.1016\/S1474-4422(22)00208-3. The authors update the Boston criteria for cerebral amyloid angiopathy. Criteria incorporate white matter changes on MRI and provide.","journal-title":"MRI-neuropathology diagnostic accuracy study. Lancet Neurol."},{"key":"1330_CR4","doi-asserted-by":"publisher","first-page":"3723","DOI":"10.1002\/hbm.23629","volume":"38","author":"YD Reijmer","year":"2017","unstructured":"Reijmer YD, Fotiadis P, Charidimou A, et al. Relationship between white matter connectivity loss and cortical thinning in cerebral amyloid angiopathy. Hum Brain Mapp. 2017;38:3723\u201331. https:\/\/doi.org\/10.1002\/hbm.23629.","journal-title":"Hum Brain Mapp"},{"key":"1330_CR5","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1093\/brain\/awu316","volume":"138","author":"YD Reijmer","year":"2015","unstructured":"Reijmer YD, Fotiadis P, Martinez-Ramirez S, et al. Structural network alterations and neurological dysfunction in cerebral amyloid angiopathy. Brain. 2015;138:179\u201388. https:\/\/doi.org\/10.1093\/brain\/awu316.","journal-title":"Brain"},{"key":"1330_CR6","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1161\/STROKEAHA.116.014337","volume":"47","author":"YD Reijmer","year":"2016","unstructured":"\u2022 Reijmer YD, Fotiadis P, Riley GA, et al. Progression of brain network alterations in cerebral amyloid angiopathy. Stroke. 2016;47:2470\u20135. https:\/\/doi.org\/10.1161\/STROKEAHA.116.014337The authors demonstrate that network impairment progresses over time and follows a pattern of progression going from posterior to frontal.","journal-title":"Stroke"},{"key":"1330_CR7","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1001\/archneur.65.6.790","volume":"65","author":"JA Pettersen","year":"2008","unstructured":"Pettersen JA, Sathiyamoorthy G, Gao FQ, et al. Microbleed topography, leukoaraiosis, and cognition in probable Alzheimer disease from the Sunnybrook dementia study. Arch Neurol. 2008;65:790\u20135. https:\/\/doi.org\/10.1001\/archneur.65.6.790.","journal-title":"Arch Neurol"},{"key":"1330_CR8","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/alzrt263","volume":"345","author":"S Martinez-Ramirez","year":"2014","unstructured":"Martinez-Ramirez S, Greenberg SM, Viswanathan A. Cerebral microbleeds: overview and implications in cognitive impairment. Alzheimers Res Ther. 2014;345:125\u201330. https:\/\/doi.org\/10.1186\/alzrt263.","journal-title":"Alzheimers Res Ther"},{"key":"1330_CR9","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.3233\/JAD-160927","volume":"56","author":"R Valenti","year":"2017","unstructured":"Valenti R, Charidimou A, Xiong L, et al. Visuospatial functioning in cerebral amyloid angiopathy: a pilot study. J Alzheimers Dis. 2017;56:1223\u20137. https:\/\/doi.org\/10.3233\/JAD-160927.","journal-title":"J Alzheimers Dis"},{"key":"1330_CR10","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.3233\/JAD-142628","volume":"45","author":"JL Whitwell","year":"2015","unstructured":"Whitwell JL, Kantarci K, Weigand SD, et al. Microbleeds in atypical presentations of Alzheimer\u2019s disease: a comparison to dementia of the Alzheimer\u2019s type. J Alzheimers Dis. 2015;45:1109\u201317. https:\/\/doi.org\/10.3233\/JAD-142628.","journal-title":"J Alzheimers Dis"},{"key":"1330_CR11","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3174\/ajnr.A4525","volume":"37","author":"AA Sepehry","year":"2016","unstructured":"Sepehry AA, Lang D, Hsiung GY, et al. Prevalence of brain microbleeds in Alzheimer disease: a systematic review and meta-analysis on the influence of neuroimaging techniques. AJNR Am J Neuroradiol. 2016;37:215\u201322. https:\/\/doi.org\/10.3174\/ajnr.A4525.","journal-title":"AJNR Am J Neuroradiol."},{"key":"1330_CR12","doi-asserted-by":"publisher","first-page":"862369","DOI":"10.3389\/fneur.2022.862369","volume":"13","author":"CG Withington","year":"2022","unstructured":"Withington CG, Turner RS. Amyloid-related imaging abnormalities with anti-amyloid antibodies for the treatment of dementia due to Alzheimer\u2019s disease. Front Neurol. 2022;13:862369. https:\/\/doi.org\/10.3389\/fneur.2022.862369.","journal-title":"Front Neurol"},{"key":"1330_CR13","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7:263\u201379. https:\/\/doi.org\/10.1016\/j.jalz.2011.03.005.","journal-title":"Alzheimers Dement"},{"key":"1330_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1148\/radiol.2018170803","volume":"287","author":"S Haller","year":"2018","unstructured":"Haller S, Vernooij MW, Kuijer JPA, et al. Cerebral microbleeds: imaging and clinical significance. Radiology. 2018;287:11\u201328. https:\/\/doi.org\/10.1148\/radiol.2018170803.","journal-title":"Radiology"},{"key":"1330_CR15","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2214\/ajr.149.2.351","volume":"149","author":"F Fazekas","year":"1987","unstructured":"Fazekas F, Chawluk JB, Alavi A, et al. MR signal abnormalities at 1.5 T in Alzheimer\u2019s dementia and normal aging. AJR Am J Roentgenol. 1987;149:351\u20136. https:\/\/doi.org\/10.2214\/ajr.149.2.351.","journal-title":"AJR Am J Roentgenol."},{"key":"1330_CR16","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.neuroimage.2006.01.021","volume":"31","author":"RS Desikan","year":"2006","unstructured":"Desikan RS, Segonne F, Fischl B, et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage. 2006;31:968\u201380. https:\/\/doi.org\/10.1016\/j.neuroimage.2006.01.021.","journal-title":"Neuroimage"},{"key":"1330_CR17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/alz.12366","volume":"18","author":"L Jakel","year":"2022","unstructured":"Jakel L, De Kort AM, Klijn CJM, et al. Prevalence of cerebral amyloid angiopathy: a systematic review and meta-analysis. Alzheimers Dement. 2022;18:10\u201328. https:\/\/doi.org\/10.1002\/alz.12366.","journal-title":"Alzheimers Dement"},{"issue":"4","key":"1330_CR18","doi-asserted-by":"publisher","first-page":"e358","DOI":"10.1212\/wnl.0000000000007818","volume":"93","author":"A Charidimou","year":"2019","unstructured":"Charidimou A, Zonneveld HI, Shams S, et al. APOE and cortical superficial siderosis in CAA: meta-analysis and potential mechanisms. Neurology. 2019;93(4):e358\u201371. https:\/\/doi.org\/10.1212\/wnl.0000000000007818.","journal-title":"Neurology"},{"key":"1330_CR19","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.jalz.2016.01.010","volume":"12","author":"JM Schott","year":"2016","unstructured":"Schott JM, Crutch SJ, Carrasquillo MM, et al. Genetic risk factors for the posterior cortical atrophy variant of Alzheimer\u2019s disease. Alzheimers Dement. 2016;12:862\u201371. https:\/\/doi.org\/10.1016\/j.jalz.2016.01.010.","journal-title":"Alzheimers Dement"},{"key":"1330_CR20","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.nicl.2017.01.012","volume":"14","author":"RS Millington","year":"2017","unstructured":"Millington RS, James-Galton M, Maia Da Silva MN, et al. Lateralized occipital degeneration in posterior cortical atrophy predicts visual field deficits. Neuroimage Clin. 2017;14:242\u20139.","journal-title":"Neuroimage Clin."}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-024-01330-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11910-024-01330-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-024-01330-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T08:26:46Z","timestamp":1707208006000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11910-024-01330-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,23]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["1330"],"URL":"https:\/\/doi.org\/10.1007\/s11910-024-01330-5","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"type":"print","value":"1528-4042"},{"type":"electronic","value":"1534-6293"}],"subject":[],"published":{"date-parts":[[2024,1,23]]},"assertion":[{"value":"14 December 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The following authors have no relevant financial or non-financial interests to disclose: LN, AM, SS, VK, AC, AT. VSP is a member of the editorial board of Current Neurology and Neurosciences Report. All other authors report no competing interests. Financial interests: VSP has received research support from NIH, the John and Joanne Hare Fund for Accelerating PCA Research, University of Colorado Alzheimer\u2019s and Cognition Center, the North American Neuro-ophthalmology Society and institutional support from the Lewy Body Dementia Association as the PI for the LBDA Research Center of Excellence; VSP has also received support from the American Academy of Neurology for editorial work, royalties from Up-to-Date, Inc., as a member of the Alzheimer\u2019s Association for the LEADS Patient Advocacy Committee, as a member of the Medical Advisory Board for Esai, and as a PI for clinical trials affiliated with Biogen and Eisai. PP has received research support from NIH, the Doris Duke Fund to Retain Clinical Scientists, and the Mary Massack Brinker Memorial Dementia Research Fund. BMB has received research support from NIH, the Department of Defense, and the University of Colorado School of Medicine. SHS has received research support from the NIH and the Alzheimer\u2019s Association. ALC is a consultant for Eli Lilly. Non-financial interests: VSP is a member of the following boards and receives no compensation as a member: Board of Directors of the North American Neuro-ophthalmology Society and the Medical Advisory Board of the Benign Essential Blepharospasm Research Foundation. ALC is a Medical Advisory Board Member of the Spinal CSF Leak Foundation and Member for the North American Neuro-ophthalmology Society Illustrated Curriculum, Brain & Life Magazine, StatPearls Behavioral Neurology and Neuropsychiatry Section, Neurology Clinical Practice, and the Journal of Neuro-ophthalmology.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}